The release of IL-6 and TNF-α is stimulated by chronic systemic inflammation, and these proinflammatory cytokines which increase vascular calcification and accelerate atherosclerosis progression, from early atheroma formation to thrombus development, may play a primary role in increasing the risk of CAD in patients with RA [5–7]. Here, IL6 is linked to coronary artery disorder.